Hantz Financial Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.49M | Sell |
79,542
-17,393
| -18% | -$1.2M | 0.09% | 204 |
|
|
2025
Q1 | $6.73M | Sell |
96,935
-87,944
| -48% | -$6.11M | 0.12% | 180 |
|
|
2024
Q4 | $15.9M | Buy |
184,879
+2,104
| +1% | +$181K | 0.28% | 68 |
|
|
2024
Q3 | $21.8M | Sell |
182,775
-2,212
| -1% | -$263K | 0.39% | 56 |
|
|
2024
Q2 | $26.4M | Buy |
184,987
+17,609
| +11% | +$2.51M | 0.51% | 45 |
|
|
2024
Q1 | $21.5M | Sell |
167,378
-8,684
| -5% | -$1.12M | 0.42% | 55 |
|
|
2023
Q4 | $18.2M | Buy |
176,062
+70,259
| +66% | +$7.27M | 0.4% | 62 |
|
|
2023
Q3 | $9.62M | Buy |
105,803
+78,477
| +287% | +$7.14M | 0.24% | 125 |
|
|
2023
Q2 | $2.21M | Buy |
27,326
+454
| +2% | +$36.7K | 0.06% | 298 |
|
|
2023
Q1 | $2.14M | Buy |
26,872
+4,598
| +21% | +$366K | 0.06% | 291 |
|
|
2022
Q4 | $1.51M | Buy |
22,274
+3,038
| +16% | +$206K | 0.05% | 324 |
|
|
2022
Q3 | $958K | Buy |
19,236
+13,898
| +260% | +$692K | 0.03% | 360 |
|
|
2022
Q2 | $297K | Buy |
+5,338
| New | +$297K | 0.01% | 479 |
|
|
2021
Q4 | – | Sell |
-5,196
| Closed | -$249K | – | 895 |
|
|
2021
Q3 | $249K | Buy |
5,196
+14
| +0.3% | +$671 | 0.01% | 468 |
|
|
2021
Q2 | $217K | Buy |
5,182
+40
| +0.8% | +$1.68K | 0.01% | 455 |
|
|
2021
Q1 | $173K | Sell |
5,142
-812
| -14% | -$27.3K | 0.01% | 443 |
|
|
2020
Q4 | $208K | Buy |
+5,954
| New | +$208K | 0.01% | 400 |
|